Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ana L. Gleisner"'
Autor:
Helen J. Madsen, Heather Carmichael, Trenton Reinicke, Ana L. Gleisner, Marco Del Chiaro, Richard D. Schulick, Camille L. Stewart
Publikováno v:
HPB. 25:431-438
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9acfbfbd998b7eff81efd29503545b73
https://doi.org/10.1016/j.hpb.2023.01.006
https://doi.org/10.1016/j.hpb.2023.01.006
Autor:
Laura D. Leonard, Laurel Beaty, Madeline Thomas, Christopher Quinn, Kathryn L. Colborn, Thiago B. de Araujo, Robert J. Torphy, Lia R. Assumpção, Kelly Olino, Christina R. Studts, Salvador Rodriguez Franco, Martin McCarter, Camille Stewart, Ana L. Gleisner
Publikováno v:
Journal of surgical oncologyREFERENCES.
Completion lymph node dissection (CLND) was the standard treatment for patients with melanoma with positive sentinel lymph nodes (SLN) until 2017 when data from the DeCOG-SLT and MLST-2 randomized trials challenged the survival benefit of this proced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e17ddf06185f82b83e81f59accaf95
https://pubmed.ncbi.nlm.nih.gov/36453464
https://pubmed.ncbi.nlm.nih.gov/36453464
Autor:
Atsushi Oba, Y H Andrew Wu, Kathryn L Colborn, Sana D Karam, Cheryl Meguid, Mohammed H Al-Musawi, Quoc R Bao, Ana L Gleisner, Steven Ahrendt, Richard D Schulick, Marco Del Chiaro
Background Neoadjuvant treatment is important for improving the rate of R0 surgical resection and overall survival outcome in treating patients with pancreatic ductal adenocarcinoma (PDAC). However, the true efficacy of radiotherapy (RT) for neoadjuv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4ad1bbea5b7cc4ecb9489172d8ba5f
https://hdl.handle.net/11577/3474097
https://hdl.handle.net/11577/3474097
Publikováno v:
Annals of surgical oncology. 29(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdb3c26b4cf30a0f4406f9f7a9e64a2b
https://pubmed.ncbi.nlm.nih.gov/34537899
https://pubmed.ncbi.nlm.nih.gov/34537899
Autor:
Alessandro, Paniccia, Ana L, Gleisner, Mazen S, Zenati, Amr I, Al Abbas, Jae Pil, Jung, Nathan, Bahary, Kenneth K W, Lee, David, Bartlett, Melissa E, Hogg, Herbert J, Zeh, Amer H, Zureikat
Publikováno v:
Annals of surgical oncology. 27(8)
Neoadjuvant therapy (NT) is a growing strategy in localized head pancreatic adenocarcinoma (PDC). However, a significant portion of NT patients do not reach resection due to disease progression or performance status decline. We sought to identify pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0afae6faa048c19473bebc434c0cca8a
https://pubmed.ncbi.nlm.nih.gov/32222859
https://pubmed.ncbi.nlm.nih.gov/32222859
Autor:
Ajacio, Brandão, Sandra C, Fuchs, Ana L, Gleisner, C, Marroni, Maria L, Zanotelli, Guido, Cantisani, Tomaz de Jesus Maria, Grezzana Filho
Publikováno v:
Clinical Transplantation. 23:220-227
Background: This study examined how reliable is the pre-trans- plant model for end-stage liver disease (MELD) score in predicting post- transplantation survival and analyzed variables associated with patient survival. Methods: A cohort study was cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054fd751825a0d475ce153b3787e2fc4
https://doi.org/10.1111/j.1399-0012.2008.00943.x
https://doi.org/10.1111/j.1399-0012.2008.00943.x
The aim of study was to assess time trends in the association between the total number of lymph nodes examined (TNLE) and survival in patients operated for adenocarcinoma of the head of pancreas.Patients operated for node-negative adenocarcinoma of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fc6ffdcb35a0f2d29cc41bfdb6d289fd
http://hdl.handle.net/11577/3312003
http://hdl.handle.net/11577/3312003
Publikováno v:
Journal of surgical oncology. 104(4)
Patients with stage IV melanoma have usually been treated with systemic therapies; however, the overall survival for patients with this approach is disappointing. A complete surgical resection of metastatic disease to stage IV sites offers the best c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::273bc4c7939e5b1e0ae720ea01493bf6
https://pubmed.ncbi.nlm.nih.gov/21858837
https://pubmed.ncbi.nlm.nih.gov/21858837
Autor:
Ajacio, Brandão, Sandra C, Fuchs, Ana L, Gleisner, Claudio, Marroni, Maria L, Zanotelli, Guido, Cantisani
Publikováno v:
Clinical transplantation. 22(5)
To examine the performance of the model for end-stage liver disease (MELD) score to predict mortality three and six months after enlistment of patients with chronic diseases for their first liver transplantation (LT) and to compare the performances o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07164d58a46ce5e182a142b941829f23
https://pubmed.ncbi.nlm.nih.gov/18549449
https://pubmed.ncbi.nlm.nih.gov/18549449